tiprankstipranks
Trending News
More News >
Genix Pharmaceuticals (TSE:GENX)
:GENX
Canadian Market

Genix Pharmaceuticals (GENX) Income Statement

Compare
1 Followers

Genix Pharmaceuticals Income Statement

Last quarter (Q3 2024), Genix Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Genix Pharmaceuticals's net income was $-82.17K. See Genix Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Oct 23Oct 22Oct 21Oct 20Oct 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 3.26K$ ―$ ―$ ―$ -45.69K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 547.42K$ 564.17K$ 536.61K$ 361.57K$ 253.00
EBITDA
$ -3.80M$ -497.69K$ -1.11M$ -353.21K$ -162.67K
Operating Income
$ -880.89K$ -1.03M$ -1.65M$ -715.21K$ -143.34K
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -4.40M$ -1.07M$ -1.65M$ -718.66K$ -164.70K
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Genix Pharmaceuticals Earnings and Revenue History